TrialAnnals of the rheumatic diseases2018

Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study.

Philip Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.